40 participants
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-28
- Start Date:
- 2026-01-14
- Completion:
- 2027-01-07
Conditions
- Prostatic Neoplasms
Interventions
- DRUG
No Results Yet